Effects of pertussis toxin and <i>Bordetella pertussis</i> lipo-oligosaccharide on the specific toxicity and potency of whole-cell pertussis vaccines

Effects of pertussis toxin and <i>Bordetella pertussis</i> lipo-oligosaccharide on the specific toxicity and potency of whole-cell pertussis vaccines

Scientific relevance. The content of Bordetella pertussis lipo-oligosaccharide (LOS) and the residual levels of active pertussis toxin (PT) are generally accepted to be the primary factors that determine the reactogenicity of whole-cell pertussis vaccines. To improve the quality of whole-cell pertus...

Full description

Bibliographic Details
Main Authors:	I. A. Alekseeva, I. V. Ibragimkhalilova, D. N. Lepekhova
Format:	Article
Language:	Russian
Published:	Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2023-10-01
Series:	Биопрепараты: Профилактика, диагностика, лечение
Subjects:	whole-cell pertussis vaccine wp vaccine potency specific toxicity vaccine reactogenicity pertussis component toxic activity <i>bordetella pertussis</i> lipo-oligosaccharide pertussis toxin
Online Access:	https://www.biopreparations.ru/jour/article/view/488

Similar Items

Pertussis vaccines and the role of <I>Bordetella pertussis</I> lipooligosaccharide in the immune response to pertussis infection and vaccination
by: I. A. Alekseeva, et al.
Published: (2021-03-01)

Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines
by: Susanna Esposito, et al.
Published: (2019-07-01)

Bordetella pertussis Strain Lacking Pertactin and Pertussis Toxin
by: Margaret M. Williams, et al.
Published: (2016-02-01)

Pasteurian Contributions to the Study of <i>Bordetella pertussis</i> Toxins
by: Camille Locht
Published: (2023-02-01)

Pertactin-Deficient Bordetella pertussis, Vaccine-Driven Evolution, and Reemergence of Pertussis
by: Longhuan Ma, et al.
Published: (2021-06-01)

Evaluation of Immunobiological Properties of Bordetella pertussis Vaccine Strains
by: I. A. Alekseeva, et al.
Published: (2018-03-01)

Evaluation of the Potency of the Pertussis Vaccine in Experimental Infection Model with <i>Bordetella pertussis</i>: Study of the Case of the Pertussis Vaccine Used in the Expanded Vaccination Program in Algeria
by: Khedidja Tahar djebbar, et al.
Published: (2022-06-01)

Pertussis Toxin: A Key Component in Pertussis Vaccines?
by: Kelsey A. Gregg, et al.
Published: (2019-09-01)

Prevention of pertussis: An unresolved problem
by: Susanna Esposito, et al.
Published: (2018-10-01)

Understanding immunity differences induced by whole cell and acellular pertussis vaccines in a paediatric population
by: Martins Valente Pinto, AM
Published: (2021)

A novel vaccine formulation candidate based on lipooligosaccharides and pertussis toxin against Bordetella pertussis
by: Jingjing Gao, et al.
Published: (2023-04-01)

Evaluation of Pertussis Toxin Expression in B2 and THIJS Media
by: H. Moradtalab, et al.
Published: (2019-03-01)

Rare Detection of Bordetella pertussis Pertactin-Deficient Strains in Argentina
by: Francisco Carriquiriborde, et al.
Published: (2019-11-01)

Evaluation of Whole-Cell and Acellular Pertussis Vaccines in the Context of Long-Term Herd Immunity
by: Ewa Szwejser-Zawislak, et al.
Published: (2022-12-01)

Antibody Specificity Following a Recent Bordetella pertussis Infection in Adolescence Is Correlated With the Pertussis Vaccine Received in Childhood
by: René H. M. Raeven, et al.
Published: (2019-06-01)

Pesquisa de antigenos aglutinantes "major" 1, 2 e 3 em cepas de Bordetella pertussis, isoladas de crianças com coqueluche atendidas no Hospital de Isolamento Emílio Ribas de São Paulo, Brasil Determination of 1, 2 and 3 major antigens in Bordetella pertussis strains isolated from Brazilian children with whooping-cough
by: Sebastião Timo Iaria
Published: (1977-09-01)

Controlling pertussis: how can we do it? A focus on immunization
by: Federico Martinón-Torres, et al.
Published: (2018-04-01)

The global prevalence ptxP3 lineage of Bordetella pertussis was rare in young children with the co-purified aPV vaccination: a 5 years retrospective study
by: Zengguo Wang, et al.
Published: (2020-08-01)

Changes in genetic diversity of the Bordetella pertussis population in Serbia between 1953 and 2011
by: Plješa Tatjana, et al.
Published: (2014-01-01)

PERTUSSIS INCIDENCE AND THE EFFECT OF REVACCINATION OF PRESCHOOL AND SCHOOL CHILDREN
by: А. M. Kostinov, et al.
Published: (2018-11-01)

Expression of <i>Bordetella pertussis</i> Antigens Fused to Different Vectors and Their Effectiveness as Vaccines
by: Han Xu, et al.
Published: (2021-05-01)

SUSCEPTIBILITY OF BORDETELLA PERTUSSIS STRAINS TO ANTIBACTERIAL PREPARATIONS
by: O. Yu. Borisova, et al.
Published: (2015-08-01)

Genetic variability of <i>Bordetella pertussis</i> and its role in vaccine prevention of pertussis
by: I. G. Bazhanova, et al.
Published: (2019-09-01)

Population Diversity among Bordetella pertussis Isolates, United States, 1935–2009
by: Amber J. Schmidtke, et al.
Published: (2012-08-01)

Acellular Pertussis Vaccine Inhibits <i>Bordetella pertussis</i> Clearance from the Nasal Mucosa of Mice
by: Jana Holubová, et al.
Published: (2020-11-01)

Consenso para el diagnóstico clínico y microbiológico y la prevención de la infección por Bordetella pertussis Consensus on the clinical and microbiologic diagnosis of Bordetella pertussis, and infection prevention
Published: (2011-02-01)

Reemergence of Pertussis in the Highly Vaccinated Population of The Netherlands: Observations on Surveillance Data
by: Hester E. de Melker, et al.
Published: (2000-08-01)

Transmission of Bordetella holmesii during Pertussis Outbreak, Japan
by: Hajime Kamiya, et al.
Published: (2012-07-01)

The Potential Role of Subclinical Bordetella pertussis Infection in Epilepsy
by: Keith Rubin, et al.
Published: (2019-08-01)

Molecular epidemiology of Bordetella pertussis and analysis of vaccine antigen genes from clinical isolates from Shenzhen, China
by: Shuang Wu, et al.
Published: (2021-08-01)

Update on pertussis and pertussis immunization
by: Jung Yun Hong
Published: (2010-05-01)

Immune persistence after pertussis vaccination
by: Zhiyun Chen, et al.
Published: (2017-04-01)

The Role of Virulence Proteins in Protection Conferred by <i>Bordetella pertussis</i> Outer Membrane Vesicle Vaccines
by: René H. M. Raeven, et al.
Published: (2020-07-01)

Characterization of a predominant Bordetella pertussis strain isolated from Iranian patients
by: VS Nikbin, et al.
Published: (2018-12-01)

Antibody avidity to pertussis toxin after acellular pertussis vaccination and infection
by: Aapo Knuutila, et al.
Published: (2023-12-01)

FEATURES OF GENOTYPiNG VARIABILITY OF STRAINS OF BORDETELLA PERTUSSIS ALLOCATED FROM PATIENTS WITH WHOOPING COUGH IN RUSSIA
by: V. A. Aleshkin, et al.
Published: (2012-09-01)

Pertussis em Portugal - A importância de uma nova estratégia vacinal Pertussis in Portugal - Time for a new strategy
by: Susana Gama de Sousa, et al.
Published: (2010-08-01)

Epidemiology of pertussis in Alberta, Canada 2004–2015
by: Xianfang C. Liu, et al.
Published: (2017-06-01)

Acellular Pertussis Vaccine Components: Today and Tomorrow
by: Kalyan K. Dewan, et al.
Published: (2020-05-01)

Antibodies to Bordetella pertussis antigens in maternal and cord blood pairs: a Thai cohort study
by: Nasamon Wanlapakorn, et al.
Published: (2017-11-01)